One third of all approved drugs target the same family of receptors: the G-Protein-Coupled Receptors (GPCRs). Now, researchers have expanded the known network of peptides that activate GPCRs by 19 percent.
This full article appears on <a href="https://www.sciencedaily.com/releases/2019/10/191031130544.htm">Science Daily</a>